Lyondell's got it all: earnings, cash flow and a huge refinery


Lyondell Chemical (NYSE: LYO) was mentioned twice as a stock to buy in this past weekend's Barron's Roundtable (subscription required), recommended by both Archie MacAllaster and John Neff. At $25, the stock is selling for 6.25x earnings, versus the S&P 500 which is selling for 15x to 16x earnings.

What is particularly attractive about Lyondell is that it bought out its Venezuelan partner's 41% stake in the Citgo refinery and now fully owns this sizable refinery. This asset should generate a lot of cash flow for Lyondell's shareholders for years to come.

Lyondell put a good chunk of debt on its balance sheet to purchase the Citgo refinery stake, but has already reduced debt by $2 to $3 billion, according to MacAllaster, who put a $40 price target on the stock.
Symbol Lookup
IndexesChangePrice
DJIA+47.0012,848.23
NASDAQ+18.822,922.70
S&P 500+5.361,348.00

Last updated: February 13, 2012: 01:08 PM

Hot Stocks

General Electric

19.045+0.17(+0.90)

Alcoa

10.355+0.065(+0.63)

Apple Inc

499.02+5.60(+1.13)

Google Inc 'A'

612.56+6.65(+1.10)

Bank of America

8.275+0.205(+2.54)

Wal-Mart Stores

61.88-0.02(-0.03)

Exxon Mobil Corp

84.34+0.54(+0.64)

Ford

12.545+0.105(+0.84)

Citigroup

33.39+0.465(+1.41)

IBM

192.80+0.38(+0.20)

Yahoo

16.15+0.01(+0.06)

Starbucks

49.16+0.34(+0.70)

Microsoft

30.58+0.085(+0.28)

Home Depot

45.815+0.485(+1.07)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

DailyFinance BlackBerry App

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

BioHealth Investor Headlines

Page Loaded in 1329156500351 ms.